Skip to main content
Biogened Spolka Akcyjna logo

Biogened Spolka Akcyjna — Investor Relations & Filings

Ticker · BGD ISIN · PLBIOGN00018 LEI · 259400JPC8O2DFHO9887 WAR Manufacturing
Open in API
Filings indexed 245 across all filing types
Latest filing 2022-06-02 Capital/Financing Update
Country PL Poland
Listing WAR BGD

About Biogened Spolka Akcyjna

http://www.biogened.pl

Biogened Spolka Akcyjna is a pharmaceutical company that develops, produces, and distributes dermo-cosmetics, dietary supplements, and medical products. The company's core focus is on its flagship brand, Dermedic, which provides specialized preparations for the care of sensitive and problematic skin. Leveraging extensive pharmaceutical knowledge and close collaboration with dermatologists, Biogened creates innovative, patent-protected solutions. Product formulations are based on unique compositions of active ingredients and incorporate the latest global trends and technologies in dermatology. The company's products are available in numerous international markets.

Recent filings

Filing Released Lang Actions
Zawarcie aneksu do umowy kredytu w rachunku bieżącym - Content (PL)
Capital/Financing Update Classification · 1% confidence The document text is a formal announcement in Polish by the Management Board ('Zarząd') of Biogened S.A. It details a material change to an existing credit agreement with BNP Paribas Bank Polska S.A., specifically extending the term and increasing the credit limit. This type of announcement concerns the company's financing activities and capital structure. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate category, as it covers updates on company fundraising and financing activities. The document is short and directly reports the change, not just announcing a separate report.
2022-06-02 Polish
Uchwala_Zarzadu_Nr_15_z_dnia_30.05.2022__-_pelnomocnictwo_w_postaci_elektronicznej.pdf
AGM Information Classification · 1% confidence The document is titled "Uchwała nr 15/2022" (Resolution No. 15/2022) issued by the Management Board of BIOGENED S.A. The content explicitly discusses the procedures for granting electronic proxies (pełnomocnictwo w postaci elektronicznej) for participation and voting rights at the upcoming Annual General Meeting (Walne Zgromadzenie Akcjonariuszy) scheduled for June 30, 2022. This resolution sets forth rules regarding shareholder voting procedures and proxy authorization for an AGM. This falls under the scope of materials related to the Annual General Meeting (AGM) or potentially Proxy Solicitation Information (PSI). Since it is a formal resolution detailing the rules for proxy submission specifically for the AGM, it is most closely aligned with AGM-R (AGM Information) or PSI. Given that it is a procedural resolution *for* the AGM, AGM-R is the most appropriate fit, as it dictates how the meeting's mechanics (like voting via proxy) will be handled, which is core AGM information. It is not a general proxy statement (DEF 14A/PSI) but a specific internal resolution governing the meeting's conduct.
2022-05-30 Polish
Projekty_uchwal_ZWZA.pdf
AGM Information Classification · 1% confidence The document text consists entirely of numbered resolutions ('UCHWAŁA Nr X') passed during a 'ZWYCZAJNEGO ZGROMADZENIA AKCJONARIUSZY' (Ordinary General Meeting of Shareholders) held on June 30, 2022. The resolutions cover procedural matters (electing a chairman, approving the agenda), approval of the 2021 financial statements (balance sheet, P&L, cash flow), approval of management/supervisory board reports, dividend allocation, and granting discharge (absolutorium) to management and supervisory board members for the 2021 fiscal year. This content is the official record of decisions made at the AGM, which aligns perfectly with the definition of 'AGM Information' (AGM-R). It is not a presentation (IP), a transcript (CT), or a formal regulatory filing like a 10-K or ER, but the outcome documentation of the meeting itself.
2022-05-30 Polish
ogloszenie_o_zwolaniu_ZWZA.doc.pdf
AGM Information Classification · 1% confidence The document is titled "Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Akcjonariuszy Biogened S.A. w Łodzi," which translates to "Announcement of the convening of the Ordinary General Meeting of Shareholders of Biogened S.A. in Łódź." The text details the date (June 30, 2022), time, location, and the detailed agenda (porządek obrad) for the meeting, including items related to approving financial statements for 2021 and voting on management discharge (absolutorium). It also provides extensive information for shareholders regarding proxy voting, submitting proposals, and registration dates. This content perfectly matches the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2022-05-30 Polish
Lista_Akcjonariuszy_BIOGENED_SA_wg_stanu_na_dzien_30.05.2022.pdf
Major Shareholding Notification Classification · 1% confidence The document text is titled "Lista Akcjonariuszy BIOGENED SA wg stanu na dzień 30 maja 2022 r." which translates to "List of Shareholders of BIOGENED SA as of May 30, 2022." It presents a table detailing major shareholders, the number of shares they hold, their percentage of the share capital, and their voting rights. This content directly relates to the ownership structure and voting power within the company. Among the provided definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit, as it deals with official results from shareholder votes and voting rights, which is intrinsically linked to the shareholder list and their associated voting power. Although it is a list of shareholders rather than the final vote tally, it is a core component of shareholder meeting documentation related to voting rights.
2022-05-30 Polish
Formularz_dla_osoby_innej_niz_osoba_fizyczna_-_zgloszenie_projektu_uchwaly.doc.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled "ZGŁOSZENIE PROJEKTU UCHWAŁY DOTYCZĄCEJ SPRAWY WPROWADZONEJ DO PORZĄDKU OBRAD ZWYCZAJNEGO WALNEGO ZGROMADZENIA" (Notification of a Draft Resolution Regarding a Matter Introduced to the Agenda of the Ordinary General Meeting). This clearly indicates it is a formal submission by a shareholder proposing an item for the agenda of an upcoming General Meeting. This type of material, which solicits or provides information related to shareholder voting and meeting procedures, aligns best with the definition of Proxy Solicitation & Information Statement (PSI), as it is directly related to the mechanics and content of a shareholder meeting, even though it is a proposal submission rather than the final proxy statement itself. It is not the AGM presentation (AGM-R), the final voting results (DVA), or a general regulatory filing (RNS). Given the context of proposing resolutions for a General Meeting, PSI is the most specific fit among the provided options.
2022-05-30 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.